CE Information – Test Course

Perioperative Analgesia for Skin Grafting

Release: 04/07/2022 Expiration: 04/07/2023

Target Audience

This activity is designed for an audience of physicians and nurses and physician assistants.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Explore the evidence base for the use of non-opioid medications to reduce opioid use in burn patients undergoing autologous skin grafting.

Criteria for Success 

To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at JGoldman@akhcme.com


akh-logo-newCE credit provided by AKH Inc., Advancing Knowledge in Healthcare.


In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Physician’s Weekly. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Credit being awarded: 0.5 ANCC contact hours


AAPA Credit Designation Statement


AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until 3/29/2023. PAs should only claim credit commensurate with the extent of their participation.

Commercial Support

There is no commercial support for this activity.



Richard Lennertz, MD, PhD
  Nothing to disclose
Dorothy Caputo, MA, BSN, RN, Senior Director of Continuing Education & Compliance
  Nothing to disclose
AKH Planners and Reviewers
  Nothing to disclose
Physician’s Weekly Planners and Reviewers
  Nothing to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.